Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-14
DOI
10.3389/fonc.2020.00960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
- (2019) Ladan Mashouri et al. Molecular Cancer
- Therapy resistance mediated by exosomes
- (2019) Teresa Bernadette Steinbichler et al. Molecular Cancer
- Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer
- (2019) Bhagyashri Kulkarni et al. DRUG DISCOVERY TODAY
- Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
- (2019) Lilly Y. W. Bourguignon Frontiers in Oncology
- Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression
- (2019) Huanhuan Li et al. LIFE SCIENCES
- Simultaneous Detection of Human C-Terminal p53 Isoforms by Single Template Molecularly Imprinted Polymers (MIPs) Coupled with Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Targeted Proteomics
- (2018) Wenting Jiang et al. ANALYTICAL CHEMISTRY
- Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non-interest
- (2018) S. F. W. M. Libregts et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
- (2018) Fanqi Meng et al. Cancer Management and Research
- Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells
- (2018) Yu Hua Quan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Exosome: a novel mediator in drug resistance of cancer cells
- (2018) He-da Zhang et al. Epigenomics
- Preparation of Exosomes for siRNA Delivery to Cancer Cells
- (2018) Farid N. Faruqu et al. Jove-Journal of Visualized Experiments
- Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells
- (2017) Lilly Y. W. Bourguignon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
- (2017) Seung Min Kim et al. JOURNAL OF CONTROLLED RELEASE
- Metabolomics–Proteomics Combined Approach Identifies Differential Metabolism-Associated Molecular Events between Senescence and Apoptosis
- (2017) Mengqiu Wu et al. JOURNAL OF PROTEOME RESEARCH
- Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity
- (2017) Aman Sharma Nanomedicine
- Comprehensive proteomics analysis of exosomes derived from human seminal plasma
- (2017) C. Yang et al. Andrology
- Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity
- (2017) Odessa Schillaci et al. Scientific Reports
- Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer
- (2016) Xiaohong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers
- (2016) Sean W. Harshman et al. Journal of Proteomics
- Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway
- (2015) Wenjuan Wang et al. MOLECULAR CARCINOGENESIS
- Effect of bFGF on the MCF-7 Cell Cycle with CD44+/CD24-: Promoting the G0/G1→G2/S Transition
- (2013) Zhen-lin Yang et al. Journal of Breast Cancer
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
- (2008) Bryan P. Toole et al. DRUG RESISTANCE UPDATES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started